ConductScience.org, home

Paper41555409

Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials.

Baseri S and 5 others. Eur J Med Res, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials. Papers, record 41555409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41555409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials.
PubMed
Journal
Eur J Med Res
PubMed
Year
2026
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baseri SSamane
2Izadi MMorteza
3Alimohammadi MMina
4Khoshnazar SMSeyedeh Mahdieh
5Nikdel RReza
6Hushmandi KKiavash

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtorvastatinMajor topic
Lung DiseasesMajor topic
LipidsMajor topic
Humans
Randomized Controlled Trials as Topic
Biomarkers
Respiratory Function Tests
Liver

Source PubMed

Download CSV of topics

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123244652Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice.Ann Allergy Asthma Immunol2013https://conductscience.org/library/papers/23244652PubMed
229392731Immune modulatory effects of statins.Immunology2018https://conductscience.org/library/papers/29392731PubMed
316896805
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Naunyn Schmiedebergs Arch Pharmacol2006https://conductscience.org/library/papers/16896805PubMed
429337684Hepatotoxicity associated with statins.Arh Hig Rada Toksikol2017https://conductscience.org/library/papers/29337684PubMed
530168753Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Am J Respir Crit Care Med2018https://conductscience.org/library/papers/30168753PubMed
616650970Characterisation of the onset and presenting clinical features of adult bronchiectasis.Respir Med2006https://conductscience.org/library/papers/16650970PubMed
710459915Inhibition of proinflammatory cytokine production by pravastatin.Lancet1999https://conductscience.org/library/papers/10459915PubMed
830211239Trial of Atorvastatin on Serum Interleukin-6, Total Antioxidant Capacity, C-Reactive Protein, and Alpha-1 Antitrypsin in Patients with Chronic Obstructive Pulmonary Disease.J Res Pharm Pract2018https://conductscience.org/library/papers/30211239PubMed
918978134Lung cancer gene associated with COPD: triple whammy or possible confounding effect?Eur Respir J2008https://conductscience.org/library/papers/18978134PubMed
1025894023Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.Ann Intern Med2015https://conductscience.org/library/papers/25894023PubMed
1115822172Pleiotropic effects of statins.Annu Rev Pharmacol Toxicol2005https://conductscience.org/library/papers/15822172PubMed
1223180589Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy.Eur Respir J2013https://conductscience.org/library/papers/23180589PubMed
1317050558Statin use is associated with reduced mortality in COPD.Eur Respir J2007https://conductscience.org/library/papers/17050558PubMed
1412117737Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.Arterioscler Thromb Vasc Biol2002https://conductscience.org/library/papers/12117737PubMed
158456658Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans.AJR Am J Roentgenol1993https://conductscience.org/library/papers/8456658PubMed
1639713070Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.World J Exp Med2024https://conductscience.org/library/papers/39713070PubMed
1715660968Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.Fundam Clin Pharmacol2005https://conductscience.org/library/papers/15660968PubMed
1817448939Statins and sepsis: multiple modifications at multiple levels.Lancet Infect Dis2007https://conductscience.org/library/papers/17448939PubMed
1934541293Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial.Int J Cardiol Heart Vasc2021https://conductscience.org/library/papers/34541293PubMed
2019349390Role for interleukin-6 in COPD-related pulmonary hypertension.Chest2009https://conductscience.org/library/papers/19349390PubMed

See all 72 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42653071Safety and Efficacy Assessment of Cannabis Plant Compared to Atorvastatin for Lipid Lowering in Diabetic and Obese Wistar Male Rats.Life (Basel)2026https://conductscience.org/library/papers/42653071PubMed
42343725Progress of Research on Cognitive Impairment in Patients With Chronic Obstructive Pulmonary Disease.Actas Esp Psiquiatr2026https://conductscience.org/library/papers/42343725PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41555409

GET https://conductscience.org/api/papers/v1/41555409/references?page=2